Inderjit Singh is an Obstetrics and Gynecologist in Falls Church, VA. Dr. Singh is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Boils, Folliculitis, Carbuncle, Ureteroscopy, and Nephrectomy.

Armine Smith, M.D. is the director of urologic oncology at the Kimmel Cancer Center at Sibley Memorial Hospital, and an associate clinical professor of urology at the Brady Urological Institute of Johns Hopkins University School of Medicine. She is a member of Greenberg Bladder Cancer Institute and the director of Women's Bladder Cancer Program at Sibley Memorial Hospital. She is also a Mary and Armeane Choksi Scholar. Dr. Smith earned her medical degree from the University of California in San Francisco. She completed a residency in urology at the Cleveland Clinic, followed by a fellowship in urologic oncology at the National Cancer Institute, where she focused on development of personalized targeted therapies for bladder cancer. Dr. Smith is a member of the Society of Urologic Oncology, American Association of Cancer Research and American Urological Association. She has been selected multiple times as a Washington, DC and Virginia top urologist. Dr. Smith specializes in advanced open, minimally invasive and robotic urologic surgery for urologic malignancies, including bladder and upper tract urothelial cancer, kidney cancer, testicular cancer, penile and urethral cancer. In bladder cancer surgery she specializes in bladder preservation, complex urinary diversions, including continent orthotopic neobladder and continent catheterizable Indiana pouch techniques. In kidney cancer, her expertise focuses on partial nephrectomy, with the goal of oncologically-sound maximum nephron-sparing surgery. She has contributed to various research, publications and presentations on topics of urology. Dr. Smith has made TV appearances, lectured domestically and internationally, and authored chapters on urothelial and kidney cancer. Her current research focuses on elucidation of risk factors for bladder cancer development, oncologically safe organ preservation in both men and women with bladder and kidney cancer and improving outcomes from bladder cancer treatments. Listen to Dr. Smith’s Cancer Matters podcast episode to learn more about her work. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. Her top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Reconstructive Urology Surgery.

Robert Mordkin is a Urologist in Arlington, Virginia. Dr. Mordkin is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Mordkin is currently accepting new patients.

Andrew Joel is a Urologist in Arlington, Virginia. Dr. Joel is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Joel is currently accepting new patients.

Wonsock Shin is a primary care provider, practicing in Internal Medicine in Vienna, Virginia. Dr. Shin is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are High Cholesterol, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Dr. Thomas W. Jarrett has an expertise in minimally invasive surgery, including laparoscopic, robotic, ureteroscopic, percutaneous and image-guided therapies. Specifically, he has an expertise in percutaneous renal surgery, laparoscopic partial and radical nephrectomy, kidney stones, urinary tract reconstruction and kidney cancer. Dr. Jarrett earned his medical degree from Emory University School of Medicine, where he also completed his internship. He completed a residency in urology at New York Hospital, followed by a visiting fellowship in urology and ultrasonography in Salzburg, Austria. Dr. Jarrett completed his fellowship in endo-urology at Long Island Jewish Medical Center. He has previously served as the chief of the division of endourology and laparoscopy at the Johns Hopkins Hospital and the chief of the division of urology at Johns Hopkins Bayview Medical Center. Dr. Jarrett has been named a Top MD by Consumers’ Checkbook Magazine and a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly. He has also been named a Super Doctor by the Washington Post. Dr. Jarrett is a member of the American Urological Association, the Society of Urologic Oncology and the Endourological Society. Dr. Jarrett has contributed to various publications and presentations on urology, earning him first prize in the World Congress of Endourology essay contest and the Faculty Research Award at Long Island Jewish Medical Center. He has editorial appointments at the Journal of Endourology and the Journal of Laparoendoscopic and Advanced Surgical Techniques. Dr. Jarrett is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Ureterocele, Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Nephrectomy, and Ureteroscopy.

Dr. Kathleen Sterling is part of the Suburban Hospital’s medical staff and a urologist with Urological Consultants, P.A. Dr. Sterling served as chief resident of the University of Maryland Medical Center urology program. During her training, she performed laboratory research related to overactive bladder. With an undergraduate degree from Vanderbilt University, Dr. Sterling served as a Surface Warfare Officer in the United States Navy, completing two deployments at sea, including one combat mission during Operation Iraqi Freedom. Dr. Sterling treats both men and women. Her expertise includes voiding dysfunction, male and female urinary incontinence and female pelvic floor disorders. Dr. Sterling’s practice also encompasses medical and surgical management of kidney stones, erectile dysfunction and urological cancers. Dr. Sterling sees patients in Bethesda and Germantown, Maryland. For appointments, call 301-530-1700. Dr. Sterling is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. Her top areas of expertise are Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Urinary Incontinence, Kidney Stones, and Ureteroscopy.

Madina Haque is a primary care provider, practicing in Internal Medicine in Arlington, Virginia. Dr. Haque is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. Her top areas of expertise are Autoimmune Hepatitis, Hepatitis, Non-Muscle Invasive Bladder Cancer, and Muscle Invasive Bladder Cancer. Dr. Haque is currently accepting new patients.

Gregory Bernstein is a Urologist in Arlington, Virginia. Dr. Bernstein is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Nephrectomy. Dr. Bernstein is currently accepting new patients.

Simon Chung is a Urologist in Fairfax, Virginia. Dr. Chung is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Prostate Cancer, Vasectomy, and Reconstructive Urology Surgery. Dr. Chung is currently accepting new patients.

Brett Holt is a Urologist in Fairfax, Virginia. Dr. Holt is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, UPJ Obstruction, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Holt is currently accepting new patients.

Edmond Paquette is a Urologist in Falls Church, Virginia. Dr. Paquette is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Paquette is currently accepting new patients.

Sunil Patel is a Urologist in Fairfax, Virginia. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), and Kidney Stones. Dr. Patel is currently accepting new patients.

Robert Reid is a Hematologist and an Oncologist in Fairfax, Virginia. Dr. Reid is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

Eric Choe is a Urologist in Fairfax, Virginia. Dr. Choe is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are UPJ Obstruction, Enlarged Prostate (BPH), Hydronephrosis, Ureteroscopy, and Prostatectomy. Dr. Choe is currently accepting new patients.

Christopher Mcmanus is a primary care provider, practicing in Internal Medicine in Arlington, Virginia. Dr. Mcmanus is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Type 1 Diabetes (T1D), and Hypertension. Dr. Mcmanus is currently accepting new patients.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

Curtiland Deville, MD, is the Medical Director of the Johns Hopkins Proton Therapy Center, Clinical Director of Radiation Oncology at Sibley Memorial Hospital, co-director of the Kimmel Cancer Center Prostate Multidisciplinary Clinic at Sibley Memorial Hospital and an Associate Professor at the Johns Hopkins University School of Medicine. Dr. Deville is an expert in proton therapy and a leader in several institutional and national clinical trials. He treats genitourinary malignancies, including prostate cancer, and soft tissue sarcomas, and is dedicated to creating individualized treatment plans for each patient. His research interests involve better targeting tumors through proton and photon therapies and reducing radiation to healthy tissues. He analyzes toxicity rates with modern radiation techniques and uses the most advanced technology for his patients’ care. Dr. Deville is also a Senior Editor for Advances in Radiation Oncology, as well as a reviewer for several journals that focus on radiation oncology. He is an expert on physician workforce diversity and widely published in the field. He is the immediate past Chair of the American Society of Radiation Oncology's Committee on Health Equity, Diversity and Inclusion and Chair of the American Society of Clinical Oncology’s Diversity in Oncology Subcommittee. LinkedIn https://www.linkedin.com/in/curtiland-deville-37133136. Dr. Deville is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Myxoid Liposarcoma, Liposarcoma, and Prostatectomy.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

Dr. Jones is a radiologist and currently serves as the Chief of Ultrasound at Sibley Memorial Hospital. He received his B.S. from Stanford University and Medical degree from the University of Wisconsin-Madison. He completed a diagnostic residency at the National Naval Medical Center, followed by a Cross-sectional Imaging fellowship at Georgetown University Hospital. Prior to joining Johns Hopkins, Dr. Jones was a staff radiologist at Suburban and Sibley Memorial Hospitals from 2004-2016. He serves as vice chairman of the Sibley Memorial Hospital Department of Radiology. Dr. Jones has subspecialty expertise in abdominal CT, MRI, ultrasound and image-guided biopsies. Dr. Jones is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Collapsed Lung, Fecal Impaction, Pleurisy, and Pleural Effusion.